US$ 27.91
mechanism of action of glp 1 receptor agonists GLP-1 as Treatments for Type 2 Diabetes Frontiers | The Impact of
Description
doi: 10.1016/j.ejphar.2008.03.025 172 GenglerSMcCleanPLMcCurtinRGaultVAHolscherC

This twice daily injectable established the entire drug class

They also incorporate dietary guidance and optional body contouring for enhanced results

Prokinetic agents like metoclopramide present a theoretical option but should be used cautiously given potential adverse effects (including tardive dyskinesia with use beyond 12 weeks) and the counterintuitive nature of accelerating gastric emptying while using a medication that intentionally slows it
